CA2196727A1 - Inhibiteur p27kip1 de la kinase cycline-dependante et methode pour reduire la resistance adherence-dependante des cellules tumorales aux agents anticancers
- Google Patents
Inhibiteur p27kip1 de la kinase cycline-dependante et methode pour reduire la resistance adherence-dependante des cellules tumorales aux agents anticancers
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Publication of CA2196727A1publicationCriticalpatent/CA2196727A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
CA 21967271996-09-161997-02-04Inhibiteur p27kip1 de la kinase cycline-dependante et methode pour reduire la resistance adherence-dependante des cellules tumorales aux agents anticancers
AbandonedCA2196727A1
(fr)
Inhibiteur p27kip1 de la kinase cycline-dependante et methode pour reduire la resistance adherence-dependante des cellules tumorales aux agents anticancers
Lipid rafts couple store-operated Ca 2+ entry to constitutive activation of PKB/Akt in a Ca 2+/calmodulin-, Src-and PP2A-mediated pathway and promote melanoma tumor growth
Utilisation pharmaceutique et produit médicamenteux utilisant un inhibiteur de lsd1 pour la prévention et le traitement du cancer du sein triplement négatif